Skip to main content
Log in

Angiotensin-converting enzyme gene polymorphisms and T2DM in a case–control association study of the Bahraini population

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Bahrain has one of the highest incidence rates of type 2 diabetes mellitus (T2DM). Development of diabetic nephropathy (DN) as a complication was noticed in some patients while absent in others. This interesting observation raises the role of certain genetic risk factors for the development of DN. Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism was found to be associated with T2DM. While some patients have predisposition to DN in the population, others have negative association. The present case–control association study was designed to investigate the association of ACE I/D polymorphism in T2DM patients in Bahrain especially in those who developed DN. A total of 360 T2DM patients (110 with DN and 250 without DN) and 360 healthy (non-diabetic) age-matched subjects were recruited for this study for comparison. The presence (insertion)/absence (deletion) (I/D) polymorphism of a 287-bp Alu1 element inside intron 16 of the ACE gene was investigated using PCR-gel electrophoresis. The results show that the distribution of the homozygote DD genotype of the ACE gene was high among Bahraini T2DM patients compared to the healthy non-diabetic subjects. In addition, the distribution of the deletion (D) allele was high among Bahraini T2DM patients with DN when compared to the healthy non-diabetic subjects. However, there was no significant difference in the distribution of ACE I/D allele and genotypes between DN patients when compared to those T2DM patients without DN. The results obtained in this study are in closely agreement with some previous reports which show a strong association of ACE polymorphism with T2DM patients, yet not a risk factor for development of DN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. King H, Rewers M (1993) Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 16:157–177

    Article  PubMed  CAS  Google Scholar 

  2. Wild R, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053

    Article  PubMed  Google Scholar 

  3. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO consultation (2006) World Health Org, Geneva

  4. Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14:S1–S85

    Article  PubMed  Google Scholar 

  5. Najjar S (2002) Regulation of insulin action by CEACAM1. Trends Endocrinol Metab 13:240–245

    Article  PubMed  CAS  Google Scholar 

  6. McLarty DG, Swai AB, Kitange HM, Masuki G, Mtinangi BL, Kilima PM, Makene WJ, Chuwa LM, Alberti KG (1989) Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet 1:871–875

    Article  PubMed  CAS  Google Scholar 

  7. Froguel P, Velho G (2001) Genetic determinants of type 2 diabetes. Recent Prog Horm Res 56:91–105

    Article  PubMed  CAS  Google Scholar 

  8. Kussman MJ, Goldstein H, Gleason RE (1976) The clinical course of diabetic nephropathy. JAMA 236:1861–1863

    Article  PubMed  CAS  Google Scholar 

  9. White KE, Bilous RW (2000) Type 2 diabetic patients with nephropathy show structural–functional relationships that are similar to type 1 disease. J Am Soc Nephrol 11:1667–1673

    PubMed  CAS  Google Scholar 

  10. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93

    Article  PubMed  CAS  Google Scholar 

  11. Woeste G, Wullstein C, Zapletal C, Hauser IA, Gossmann J, Geiger H, Bechstein WO (2006) Evaluation of type 1 diabetics for simultaneous pancreas-kidney transplantation with regard to cardiovascular risk. Transplant Proc 38:747–750

    Article  PubMed  CAS  Google Scholar 

  12. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–266

    Article  Google Scholar 

  13. Ritz E, Orth SR (1999) Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127–1133

    Article  PubMed  CAS  Google Scholar 

  14. Yang WC, Hwang SJ, Taiwan Society of Nephrology (2008) Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 23:3977–3982

    Article  PubMed  Google Scholar 

  15. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS Group (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225–232

    Article  PubMed  Google Scholar 

  16. Sarnak MJ, Levey AS (2000) Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35:S117–S131

    Article  PubMed  CAS  Google Scholar 

  17. Park HC, Choi SR, Kim BS, Lee TH, Kang BS, Choi KH, Lee HY, Han DS, Ha SK (2005) Polymorphism of the ACE Gene in dialysis patients overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med J 46:779–787

    Article  PubMed  CAS  Google Scholar 

  18. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion deletion polymorphism in angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346

    Article  PubMed  CAS  Google Scholar 

  19. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197–205

    PubMed  CAS  Google Scholar 

  20. Arzu Ergen H, Hatemi H, Agachan B, Camlica H, Isbir T (2004) Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med 36:345–350

    PubMed  CAS  Google Scholar 

  21. Obineche EN, Frossard PM, Bokhari AM (2001) An association study of five genetic loci and left ventricular hypertrophy amongst Gulf Arabs. Hypertens Res 24:635–639

    Article  PubMed  CAS  Google Scholar 

  22. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A (2000) ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in Whites. Arterioscler Thromb Vasc Biol 20:484–492

    PubMed  CAS  Google Scholar 

  23. Zee RY, Ridker PM, Stampfer MJ, Hennekens CH, Lindpaintner K (1999) Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation 99:340–343

    PubMed  CAS  Google Scholar 

  24. Ramachandran V, Ismail P, Stanslas J, Shamsudin N, Moin S, Mohd Jas R (2008) Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone Syst 9:208–214

    Article  PubMed  CAS  Google Scholar 

  25. Gesang L, Liu G, Cen W, Qiu C, Zhuoma C, Zhuang L, Ren D, Pincuo Z, Chan Y (2002) Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population. Hypertens Res 25:481–485

    Article  PubMed  CAS  Google Scholar 

  26. Ortega-Pierres LE, Gómez García A, Rodríguez-Ayala E, Figueroa-Núñez B, Farias-Rodríguez VM, Higareda-Mendoza AE, Pardo-Galván MA, Cortés-García JC, López-Meza JE, Alvarez-Aguilar C (2007) Angiotensin-1 converting enzyme insertion/deletion gene polymorphism in a Mexican population with diabetic nephropathy. Med Clin (Barc) 129:6–10

    Article  Google Scholar 

  27. Movva S, Alluri RV, Komandur S, Vattam K, Eppa K, Mukkavali KK, Mubigonda S, Saharia S, Shastry JC, Hasan Q (2007) Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J Diabetes Complicat 21:237–241

    Article  PubMed  Google Scholar 

  28. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, Jayaraman M, Sharma K (2001) Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP 2:83–87

    PubMed  CAS  Google Scholar 

  29. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T (1998) Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41:47–53

    Article  PubMed  CAS  Google Scholar 

  30. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F (1997) Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585–1595

    Article  PubMed  CAS  Google Scholar 

  31. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O (1996) Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657–664

    Article  PubMed  CAS  Google Scholar 

  32. Al-Mahroos F, McKeigue PM (1998) High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 21:936–942

    Article  PubMed  CAS  Google Scholar 

  33. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, Forouzanfar M, Gregg EW (2008) Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 31:96–98

    Article  PubMed  Google Scholar 

  34. Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433 (an abstract)

    Article  PubMed  CAS  Google Scholar 

  35. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706–711

    Article  PubMed  CAS  Google Scholar 

  36. Shanmugan V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods Appl 3:120–121

    Google Scholar 

  37. Kumar PJ, Clark ML (2007) Diabetes mellitus and other endocrine disorders. In: Kumar PJ, Clark ML (eds) Textbook of clinical medicine chapter 19, 7th edn. Saunders, London, pp 1069–1121

    Google Scholar 

  38. Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ, Humphries SE (2005) The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 84:83–89

    Article  PubMed  CAS  Google Scholar 

  39. Degirmenci I, Kebapci N, Basaran A, Efe B, Gunes HV, Akalin A, Kurt H, Urhan M, Demirustu C (2005) Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract 59:1137–1142

    Article  PubMed  CAS  Google Scholar 

  40. Lee YJ, Tsai JC (2002) ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25:1002–1008

    Article  PubMed  CAS  Google Scholar 

  41. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R, Wang G, Xu X (2002) Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 51:1986–1988

    Article  PubMed  CAS  Google Scholar 

  42. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, Tsai JH (2000) Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 15:1008–1013

    Article  PubMed  CAS  Google Scholar 

  43. Chuang LM, Chiu KC, Chiang FT, Lee KC, Wu HP, Lin BJ, Tai TY (1997) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 46:1211–1214

    Article  PubMed  CAS  Google Scholar 

  44. Nitiyanant W, Sriussadaporn S, Ploybutr S, Watanakejorn P, Tunlakit M, Bejrachandra S (1997) Angiotensin converting enzyme gene polymorphism in healthy Thais and patients with non-insulin dependent diabetes mellitus. J Med Assoc Thai 80:747–752

    PubMed  CAS  Google Scholar 

  45. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E (1997) Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 12:427–429

    Article  PubMed  CAS  Google Scholar 

  46. Ha SK, Park HC, Park HS, Kang BS, Lee TH, Hwang HJ, Kim SJ, Kim DH, Kang SW, Choi KH, Lee HY, Han DS (2003) ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy. Am J Kidney Dis 41:943–949

    Article  PubMed  CAS  Google Scholar 

  47. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma AM (1998) Association between the angiotensin-converting enzyme -insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol 9:1653–1663

    PubMed  CAS  Google Scholar 

  48. Tarnow L (1996) Genetic pattern in diabetic nephropathy. Nephrol Dial Transplant 11:410–412

    PubMed  CAS  Google Scholar 

  49. Fava S, Azzopardi J, Ellard S, Hattersley AT (2001) ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease. Diabetes Care 24:2115–2120

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Special thanks for Colonel Dr. Abdulla Darweesh Chairman of Department of Pathology in BDF Hospital & Major Khalid Matar, Chief of Medical Technologists for giving the opportunity to collect blood samples, for the current study, from the BDF Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Einas M. Al-Harbi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Harbi, E.M., Farid, E.M., Gumaa, K.A. et al. Angiotensin-converting enzyme gene polymorphisms and T2DM in a case–control association study of the Bahraini population. Mol Cell Biochem 350, 119–125 (2011). https://doi.org/10.1007/s11010-010-0688-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-010-0688-y

Keywords

Navigation